Vijaya Diagnostic Centre Ltd (VIJAYA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Vijaya Diagnostic Centre Ltd on NSE and BSE, with an AI summary of each filing.
Audio recording of the Earning Conference Call for Q2 - FY 2027
Audio / Video · 04 Nov 2026, 10:35 pm
Vijaya Diagnostic Centre Releases Q2-FY27 Earnings Call Audio Recording Vijaya Diagnostic Centre Limited has submitted the audio recording link for its Q2 and H1-FY27 earnings conference call held on 4th Nov'26, following the declaration of unaudited financial results for the quarter and half year ended 30th Sep'26. The disclosure complies with Regulations 30 and 46 of SEBI LODR Regulations, with the recording hosted on the company's official website.
Investor Presentation on unaudited Financial Results for Quarter and Half Year Ended September 30, 2026
Investor Presentation · 04 Nov 2026, 2:03 am
Vijaya Diagnostic Centre Reports Robust Q2 FY27 Results with 37.4% YoY PAT Growth Vijaya Diagnostic Centre delivered strong Q2 FY27 performance, with revenue from operations growing 26.7% YoY to INR 2,554 Mn, driven by a 16.5% YoY rise in test volumes to 4.98 Mn and 14.5% footfall growth. EBITDA increased 37.8% YoY to INR 1,128 Mn with margins expanding 355 bps to 44.1%. PAT surged 37.4% YoY to INR 595 Mn. The B2C segment maintained a 92% revenue share. Strategically, the company expanded into the North-East by signing a BTA to acquire Arya Wellness Centre for INR 462 Mn.
Press-release on unaudited Financial Results for the Quarter and half year ended September 30, 2026
Press Release · 04 Nov 2026, 1:56 am
Vijaya Diagnostic Centre Delivers Strong Q2 FY27 Results with 37.4% PAT Growth For the quarter ended 30th Sep'26, Vijaya Diagnostic Centre posted a 26.7% YoY increase in revenue from operations to Rs 2,553.9 Mn, backed by 16.5% test volume growth. EBITDA rose 37.8% YoY to Rs 1,127.5 Mn with margins expanding 355 bps to 44.1%. PAT grew 37.4% YoY to Rs 594.7 Mn. Average realization per footfall increased 10.6% YoY to Rs 1,865. The company entered the North-East market via the acquisition of Arya Wellness Centre in Guwahati and plans to add 3 hubs and 7 spokes in H2 FY27.
Appointment of Mr. Rahul Jain (ICSI M. No. A62949), as Company Secretary and Compliance Officer of the Company
Change in Management · 04 Nov 2026, 1:46 am
Vijaya Diagnostic Centre Appoints Rahul Jain as Company Secretary and Compliance Officer Vijaya Diagnostic Centre Limited has appointed Rahul Jain (ICSI M. No. A62949) as Company Secretary, Compliance Officer, and Key Managerial Personnel, effective 3rd Nov'26. The appointment was approved by the Board of Directors upon the recommendation of the Nomination and Remuneration Committee. Jain brings over six years of professional experience across corporate secretarial functions, corporate governance, and regulatory compliances under SEBI and Companies Act frameworks.
Submission of the Unaudited Financial Results for the Quarter and Half year ended September 30, 2026
Financial Result · 04 Nov 2026, 1:40 am
The Board of Directors in their meeting held on November 03, 2026 have approved the financial results for the quarter and Half year ended September 30, 2026
Outcome · 04 Nov 2026, 1:32 am
Vijaya Diagnostic Centre Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 25,539 (+26.7% YoY | +10.6% QoQ) ■ EBITDA: 11,275 (+37.8% YoY | +14.4% QoQ) ■ EBITDA Margin (%): 44.1 (+355 bps YoY | +149 bps QoQ) ■ PAT: 5,947 (+37.4% YoY | +12.0% QoQ) ■ EPS (INR): 5.76 (+37.1% YoY | +11.8% QoQ)
Vijaya Diagnostic Centre Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 04 Nov 2026, 1:27 am
Vijaya Diagnostic Centre Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Initmation of Earning Conference Call
Intimation · 04 Nov 2026, 11:00 am
Vijaya Diagnostic Schedules Q2FY27 Earnings Conference Call Vijaya Diagnostic Centre Limited will host its Q2FY27 earnings conference call on 4th Nov'26 at 11:00 AM IST to discuss financial results for the quarter and half-year ended 30th Sep'26. The call will be hosted by JM Financial Institutional Securities and attended by key management, including MD & CEO Suprita Reddy, COO Siva Rama Raju Vegesna, CFO Narasimha Raju, and Head of IR Dhiren Gala. Universal dial-in numbers are +91 22 6280 1366 and +91 22 7115 8267.
To consider and approve the financial results for the Quarter and Half year ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the unaudited Financial ....
Intimation · 03 Nov 2026, 5:30 am
Vijaya Diagnostic Centre Schedules Board Meeting to Approve Q2 FY27 Results Vijaya Diagnostic Centre Limited has scheduled its Board of Directors meeting for 3rd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26, alongside other corporate matters. Additionally, the trading window for dealing in company securities, which closed on 1st Oct'26 for all designated persons and immediate relatives, will remain shut until 5th Nov'26 (48 hours post-financial results announcement).
Voting Results along with the Scrutiniser Report of the 24th AGM Held on 24th September 2026.
Annual General Meeting · 26 Sept 2026, 6:35 pm
Summary of the proceedings of the 24th AGM of the Company held on Thursday, 24th September 2026 at 11:00 am through VC/OAVM.
Annual General Meeting · 24 Sept 2026, 9:36 pm
100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam.
Investor Presentation · 12 Sept 2026, 2:31 am
Vijaya Diagnostic Acquires Arya Wellness Centre for ₹46 Crore Vijaya Diagnostic Centre signed a Business Transfer Agreement on 10th Sep'26 to acquire 100% of Guwahati-based Arya Wellness Centre via a slump sale for ~₹46 Cr (~8-9x FY26 EBITDA), funded via internal accruals. The deal expands Vijaya's network to 167 centres across 7 states, providing entry into the North-East market. In FY26, Arya Wellness generated revenue of INR 260 Mn, EBITDA of INR 56 Mn (21.4% margin), and PAT of INR 25 Mn. The acquisition is EPS accretive from onset, with closing expected by Nov/Dec'26.
Execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on slump sale.
Press Release · 12 Sept 2026, 2:10 am
Vijaya Diagnostic Acquires Arya Wellness Centre for ~INR 46 Crore Vijaya Diagnostic Centre agreed on 11th Sep'26 to acquire a 100% stake in Guwahati-based Arya Wellness Centre via a slump sale for ~INR 46 cr, marking its entry into North-East India. The deal is valued at ~8–9x FY26 IND AS EBITDA and is expected to be EPS accretive from the outset, closing within ~three months. In FY26, Arya Wellness Centre generated ~INR 26 cr in revenue (56% pathology, 44% radiology), INR 5.6 cr in EBITDA, and INR 2.5 cr in adjusted PAT, with over 85% revenue from B2C.
Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis subject to the fulfilment of Conditions Precedent (CPs) and other terms and conditions as set out in the BTA.
Outcome · 12 Sept 2026, 1:29 am
Vijaya Diagnostic Acquires Arya Wellness Diagnostic Business for ₹46.20 Crore Vijaya Diagnostic Centre approved acquiring the integrated diagnostic business of Guwahati-based Arya Wellness Centre from NEMRIL HRPL JV on a slump sale basis for ₹46.20 Cr in cash. The acquisition strengthens Vijaya's presence in Assam and North-East India, granting 100% operational control. The target business provides pathology and radiology services, reporting FY25-26 turnover of ₹26.95 Cr (FY24-25: ₹25.61 Cr; FY23-24: ₹22.99 Cr). The transaction is expected to close within 90 days, subject to regulatory approvals and customary closing adjustments.
Outcome of Board Meeting under Regulation 30 of SEBI (LODR) Regulations, 2015 - Approval for Execution of Business Transfer Agreement (BTA) for 100% acquisition of the integrated diagnostic ....
Others (Uncategorized) · 12 Sept 2026, 1:16 am
Vijaya Diagnostic Centre to Acquire Arya Wellness Centre for ₹46.20 Crore Vijaya Diagnostic Centre's Board approved the acquisition of Arya Wellness Centre's integrated diagnostic business from NEMRIL HRPL JV on a slump sale basis for a cash consideration of ₹46.20 crore. The deal expands Vijaya's diagnostic footprint into Assam and North-East India, granting 100% operational control. The target business, based in Guwahati, reported revenues of ₹26.95 crore in FY'26, ₹25.61 crore in FY'25, and ₹22.99 crore in FY'24. The transaction is expected to close within 90 days, subject to regulatory approvals and customary closing conditions.
Institutional Investor Meeting hosted by Emkay Global.
Intimation · 03 Sept 2026, 12:26 am
Vijaya Diagnostic Centre Schedules Institutional Investor Meeting on 10th Sep'26 Vijaya Diagnostic Centre officials will participate in an in-person Institutional Investor Meeting hosted by Emkay Global on 10th Sep'26 at 11:00 a.m. (IST). The interactions will feature group and one-on-one meetings held at the company's JP Nagar facility in Bengaluru. Management confirmed that discussions will be strictly restricted to publicly available information, and no unpublished price-sensitive information (UPSI) will be disclosed during the engagements.
Appointment of Chief Information Officer (CIO)
Change in Management · 02 Sept 2026, 11:19 pm
Vijaya Diagnostic Centre Appoints Dr. Venkata Naresh Yallapragada as Chief Information Officer Vijaya Diagnostic Centre Limited appointed Dr. Venkata Naresh Yallapragada as Chief Information Officer, effective 2nd Sep'26. A seasoned healthcare IT leader with over 23 years of experience, Dr. Yallapragada previously held Group CIO/CTO roles at prominent Indian hospital networks, including publicly listed KIMS Hospitals and Rainbow Children's Medicare, as well as Maxivision Eye Hospitals. His expertise spans HIS/EMR implementations, SAP ERP integrations, AI-driven CRM systems, and cybersecurity infrastructure, positioning Vijaya Diagnostic to strategically strengthen its digital transformation and enterprise analytics capabilities.
Resignation of Company secretary
Change in Management · 26 Aug 2026, 11:54 pm
Vijaya Diagnostic: Company Secretary & Compliance Officer Resigns Vijaya Diagnostic Centre announced the resignation of Ms. Naga Vasudha Tadepalli, Company Secretary & Compliance Officer, effective 26 Aug'26. The company filing cited personal reasons for her departure. The resignation marks a change in key managerial personnel for the diagnostic firm.
Weblink to Shareholders
Others (Uncategorized) · 26 Aug 2026, 10:23 pm
Vijaya Diagnostic Announces 24th AGM and FY26 Annual Report Access Vijaya Diagnostic Centre will hold its 24th Annual General Meeting (AGM) via video conference on 24th Sep'26 at 11:00 AM IST. In compliance with SEBI regulations, the company has provided a weblink for its FY 2025-26 Annual Report. This communication, dated 26th Aug'26, was sent to shareholders whose email addresses were not registered as of the 21st Aug'26 cut-off date. The company urged these members to update their email details with their Depository Participant for future electronic communications.
Record date for final dividend and e-voting for AGM
Dividend · 26 Aug 2026, 10:13 pm
BRSR for FY 2025-26
Others (Uncategorized) · 26 Aug 2026, 10:11 pm
Vijaya Diagnostic FY26 BRSR: Key ESG Metrics & Operational Highlights Vijaya Diagnostic's FY26 BRSR, issued on 26 Aug'26, shows operations across 162 labs in 6 Indian states. FY26 turnover was ₹7,654.29 million with a net worth of ₹9,434.53 million. Capex for environmental/social impact technologies was 69.22% of total capex, up from 65.67% in FY25. The company reported 3,244 total employees, with permanent employee turnover at 33.15%. Gross wages paid to females were 31.00% of total wages. In FY26, 8,413 customer complaints were filed for service delivery, up from 6,462 in FY25.
Annual Report for FY 2025-26
Others (Uncategorized) · 26 Aug 2026, 10:06 pm
Notice of 24th Annual General Meeting of the Company
Annual General Meeting · 26 Aug 2026, 10:01 pm